Bicycle Therapeutics

They didn’t wait for the next advance against cancer. They created it.

About

Bicycle Therapeutics is a biotherapeutics company commercializing a new class of therapeutics and drug delivery mechanisms known as bicycles®. This is a platform technology that has applications both within and beyond and shows great promise. This company was co-founded by Ahren Science Partner Sir Gregory Winter (who invented Humira the world’s highest grossing drug with ~$20BN revenues in 2018). Bicycle Therapeutics was listed on the Nasdaq in Q2 2019, our first IPO, raising $60M at a valuation of c.$200M.

Key People

Nick Keen
Kevin Lee
Sir Gregory Winter

Domain

Genetics & Platform Technologies

prev company Adrestia Therapeutics next company Cambridge Epigenetix

We use cookies to give you the best experience on our website. Learn more.

accept